31 reports

He has experience in designing and executing an operational research study on HIV/ AIDS services uptake among high risk groups (HRGs) in India.

  • Dementia
  • Spain
  • United States
  • World
  • Forecast

The high prevalence of HIV/ AIDS in South Africa is seen as the key factor in the low life expectancy, which is impeding the development of the country, affecting maintenance of healthcare services, as well as the provision of medical genetic services.

  • Dementia
  • North America
  • United States
  • World
  • Forecast
  • Global Alzheimer's Disease Market Size, By Value (USD Billion) and Volume (Number of
  • Global Alzheimer's Disease Market Outlook

Executive Summary Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease. The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population...

  • Dementia
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Novartis AG
  • Pfizer Inc.

HE HAS EXPERIENCE IN DESIGNING AND EXECUTING AN OPERATIONAL RESEARCH STUDY ON HIV/ AIDS SERVICES UPTAKE AMONG HIGH RISK GROUPS (HRGS) IN INDIA.

  • Dementia
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

She is a medical doctor and has worked extensively in public health research and its implementation, including involvement in the Tuberculosis Program under the Revised National Tuberculosis Control Program (RNTCP), HIV/ AIDS Awareness Program, Infectious Diseases Programs, Imm

  • Dementia
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • ESCHERICHIA COLI INFECTIONS

Toll Like Receptor 4 (hToll or CD284 or TLR4) - Pipeline Review, H1 2018 Summary Toll Like Receptor 4 (hToll or CD284 or TLR4) - Toll-like receptor 4 is a protein encoded by the TLR4 gene. This receptor is mostly expressed in placenta, and in myelomonocytic subpopulation of the leukocytes. It is...

  • Dementia
  • Digestive System Disorder
  • Hospital
  • Therapy
  • MediciNova, Inc.
  • 3.3 MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES (DROC)

AD is also underfunded, as National Institute of Health (NIH) dedicated USD ##. ## billion to cancer research in 2013, nearly USD ## billion to HIV/ AIDS, USD ##. ## billion to heart disease, and Alzheimer' s disease research only received USD ## million.

  • Dementia
  • Therapy
  • United States
  • Market Size
  • Eisai Co., Ltd.
  • Official Title
  • 5. All the trials included are unique trials.

The TRIANT-TE Study Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection.

  • Clinical Trial
  • Dementia
  • Drug Discovery And Development
  • Pharmaceutical
  • World

AIDS Associated Dementia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* Prominent Drugs AIDS Associated Dementia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* AIDS Associated Dementia Therap

  • Dementia
  • HIV AIDS
  • Neurology
  • World
  • Product Initiative

It provides preclinical and clinical proof to support further development of TriMix technology. eTheRNA also develops drugs for infectious diseases such as influenza, pneumonia, tuberculosis, Lyme disease, HIV and AIDS et cetera.

  • Blood Disease
  • Dementia
  • United States
  • World
  • MediciNova, Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Dementia
  • Neurology
  • World
  • Product Initiative
  • ALZHEIMER'S DISEASE - PIPELINE BY RODOS BIOTARGET GMBH
  • ALZHEIMER'S DISEASE - PIPELINE BY SAGE THERAPEUTICS INC

Its targosphere finds application in treating various infectious diseases such as virus caused HCV/ hepatitis c and HIV/ AIDS; and bacteria caused tuberculosis, legionellosis, and methicillin-resistant staphylococcus aureus.

  • Dementia
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Clinical Trial profile. 733 Trial Title
  • 5. All the trials included are unique trials.

The TRIANT-TE Study Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection.

  • Clinical Trial
  • Dementia
  • Neurology
  • Pharmaceutical
  • Therapy
  • Featured News & Press Releases

In recent years science has made huge leaps forward in tackling diseases like cancer and HIV/ AIDS, and despite set-backs like this, we will be able to tackle diseases like Alzheimer' s if we continue to invest in research. "

  • Dementia
  • Therapy
  • United States
  • World
  • Product Initiative

A team at UCLA was awarded $##. ## million to develop a way to genetically modify blood stem cells to help make the immune system resistant to the AIDS virus as a potential treatment and even cure for HIV/ AIDS.

  • Dementia
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Irvine Company

Brass, M. D., Ph. D. - A CRISPR/ Cas## Screen to Discover HIV-## Latency Factors Frederick National Laboratory for Cancer Research, AIDS and Cancer Virus Program - Jeffrey D.

  • Dementia
  • Gene Therapy
  • Therapy
  • United States
  • Gilead Sciences, Inc.

MSL IS INDICATED FOR THE TREATMENT OF TS##-INDUCED NEURODEGENERATION IN THE MURINE RETROVIRUS TS## MODEL, AMYOTROPHIC LATERAL SCLEROSIS (ALS), HIV ASSOCIATED DEMENTIA AND GULF WAR ILLNESS.

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

EUKARYOTIC TRANSLATION INITIATION FACTOR (EIF##A) IS REQUIRED FOR HIV-## REPLICATION.

  • Cell Therapy
  • Dementia
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Clinical Trial profile. 226 Trial Title
  • Clinical Trial Profile Snapshots

Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Dementia
  • Neurology
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 348 Trial Title
  • Clinical Trial profile. 1094 Trial Title

Cognitive Disorders Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Disorders....

  • Clinical Trial
  • Dementia
  • Drug Discovery And Development
  • Pharmaceutical
  • World

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Dementia
  • Research And Development
  • United States
  • Company Operations
  • Suven Life Sciences Ltd
  • Bacterial Sepsis

Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016’, provides in depth analysis on Toll Like Receptor 4 (CD284 or TLR4) targeted pipeline therapeutics. The report provides comprehensive information on...

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • MediciNova, Inc.

HD patients carry one functional allele and one mutated allele.

  • Dementia
  • Neurological Disorder
  • Therapy
  • United States
  • Product Initiative

In February 2010, Bach Pharma, Inc filed a patent with the application (PCT/ US2010/ ##) entitled with Methods of treating intestinal diseases and inflammatory conditions related to HIV- AIDS".

  • Dementia
  • Therapy
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

In February 2010, Bach Pharma, Inc filed a patent with the application (PCT/ US2010/ ##) entitled with Methods of treating intestinal diseases and inflammatory conditions related to HIV- AIDS".

  • Cell Therapy
  • Dementia
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.
  • ALZHEIMER'S DISEASE - PIPELINE BY REGENERA PHARMA LTD, H1 2018
  • ALZHEIMER'S DISEASE - PIPELINE BY REMYND NV, H1 2018

Its targosphere finds application in treating various infectious diseases such as virus caused HCV/ hepatitis c and HIV/ AIDS; and bacteria caused tuberculosis, legionellosis, and methicillin-resistant staphylococcus aureus.

  • Dementia
  • Pathology
  • Research And Development
  • Company
  • Anavex Life Sciences Corp.
  • ALZHEIMER'S DISEASE - PIPELINE BY SAGE THERAPEUTICS, INC.,
  • ALZHEIMER'S DISEASE - PIPELINE BY RODOS BIOTARGET GMBH,

It develops gene-based drugs that cure liver cancer, HIV/ AIDS, Parkinson' s disease, and diabetes.

  • Dementia
  • Pathology
  • United States
  • Company
  • Product Initiative
  • ALZHEIMER'S DISEASE - PIPELINE BY RODOS BIOTARGET GMBH, H2 2016
  • ALZHEIMER'S DISEASE - PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H2 2016

Alzheimer's Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alzheimer's Disease, complete...

  • Dementia
  • Hospital
  • Pathology
  • United States
  • Anavex Life Sciences Corp.

The company focuses on the areas including cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Dementia
  • Research And Development
  • Therapy
  • United States
  • Company Operations

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Dementia
  • Research And Development
  • United States
  • Company Operations
  • Suven Life Sciences Ltd